Status:
RECRUITING
COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study
Lead Sponsor:
Hospices Civils de Lyon
Collaborating Sponsors:
BioMérieux
Conditions:
Intensive Care Unit
SARS-Cov-2
Eligibility:
All Genders
18+ years
Brief Summary
Infection with the SARS-CoV-2 coronavirus (COVID-19) has recently been identified as a pandemic due to the speed and global scale of its transmission. In Auvergne-Rhône-Alpes region (AURA), the epidem...
Eligibility Criteria
Inclusion
- Man or woman aged 18 or over,
- Hospitalization in intensive care for Sars-Cov-2 pneumopathy,
- First hospitalization in intensive care unit,
- Positive diagnosis of SARS-CoV2 infection carried out by PCR or by another approved method in at least one respiratory sample,
- Sampling in the first 24 hours after admission to intensive care unit (D0 / D1) feasible,
- Patient or next of kin who has been informed of the terms of the study and has not objected to participating.
Exclusion
- Pregnant or lactating woman,
- Person placed under legal protection,
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04392401
Start Date
May 11 2020
End Date
April 1 2026
Last Update
December 17 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pierre Wertheimer
Bron, France, 69500
2
Hôpital Gabriel Montpied
Clermont-Ferrand, France, 63000
3
Centre hospitalier universitaire de Grenoble Alpes
Grenoble, France, 38043
4
Hôpital Edouard Herriot
Lyon, France, 69003